A new genetic variant in individuals who are APOE4 carriers is linked to a 70% reduction in the risk for Alzheimer's disease (AD), new research suggested. The variant occurs on the fibronectin 1 (FN1) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results